Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovobot is a Montreal-based investment and innovation platform focused on deep technology rather than therapeutics or drug development. The organization combines an innovation studio, Innovobot Labs, with an early-stage investment arm, Innovobot Resonance Ventures, to help startups and established companies develop and commercialize advanced technologies. Its technical focus areas include robotics, artificial intelligence, human-machine interaction, Internet of Things, advanced materials, and related engineering disciplines. Innovobot also provides product development and commercialization support for complex systems, including work relevant to regulated sectors such as medical devices, but it is not primarily a biotech, pharma, or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovobot.